BOSTON and SHANGHAI, Sept. 24, 2024 /PRNewswire/ -- Today, XtalPi announced the official launch of XFEP and XMolGen, two proprietary software products designed to accelerate and enhance the efficiency of drug discovery. Upon this launch, XtalPi will offer commercial licenses with flexible terms for industrial and academic scientists to use the software based on their research goals. With user-friendly interfaces, these platforms are seamlessly integrated within a shared suite to enable streamlined drug discovery workflows.